Export

You can select particular sections to be included in the output file.

Model List of Essential Medicines

clear Found 5 recommendations for 5 medicines and 0 therapeutic equivalents
Removed medicines and rejected applications are not shown. Show them.
6.4.4.2.2. Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
  1. Dasabuvir General information
    Section
    Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
    • Oral > Solid: 250 mg tablet
    Indications
    Chronic hepatitis C
  2. Ledipasvir + sofosbuvir General information
    Section
    Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
    • Oral > Solid: 90 mg + 400 mg tablet
    Indications
    Chronic hepatitis C
  3. Ombitasvir + paritaprevir + ritonavir General information
    Section
    Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations
    • Oral > Solid: 12.5 mg + 75 mg + 50 mg tablet
    Indications
    Chronic hepatitis C